Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells

Attenuated measles virus (MV) is currently being evaluated in clinical trials as an oncolytic therapeutic agent. Originally used for its lytic activity against tumor cells, it is now admitted that the effectiveness of MV also lies in its ability to initiate antitumor immune responses through the act...

Descripción completa

Detalles Bibliográficos
Autores principales: Achard, Carole, Guillerme, Jean-Baptiste, Bruni, Daniela, Boisgerault, Nicolas, Combredet, Chantal, Tangy, Frédéric, Jouvenet, Nolwenn, Grégoire, Marc, Fonteneau, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283625/
https://www.ncbi.nlm.nih.gov/pubmed/28197384
http://dx.doi.org/10.1080/2162402X.2016.1261240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283625/
https://www.ncbi.nlm.nih.gov/pubmed/28197384
http://dx.doi.org/10.1080/2162402X.2016.1261240

Ejemplares similares